13F

Stock

Akari Therapeutics Plc

AKTX · held by 21 managers

Reported value

$1.29M

Holders

21

+0 new · −0 exited

Holders’ est. mark

−$593.1K

Price effect on 3 books still in the name

Largest holder

$787.2K

ARMISTICE CAPITAL, LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
ARMISTICE CAPITAL, LLC2.72M$787.2KHeld
Cresset Asset Management, LLC822.5K$237.7K−$593KCut−$593K
Warberg Asset Management LLC308.3K$88.7KHeld
Palo Alto Investors LP146K$42.2KHeld
HighTower Advisors, LLC79.2K$22.9KHeld
JANE STREET GROUP, LLC71.6K$20.7KHeld
SmartHarvest Portfolios, LLC69.2K$20KHeld
CWA Asset Management Group, LLC55K$15.9KHeld
XTX Topco Ltd49K$14.2KHeld
UBS Group AG32.9K$9.5KHeld
Cerity Partners LLC23.6K$6.83KHeld
StoneX Group Inc.21.3K$6.15KHeld
Skyview Financial Group LLC20.6K$5.95KHeld
Independent Advisor Alliance17.1K$4.93KHeld
NewEdge Advisors, LLC6.8K$1.97KHeld
Accent Capital Management, LLC5K$1.45KHeld
BANK OF AMERICA CORP /DE/410$118−$109Cut−$34
SBI Securities Co., Ltd.200$58Held
Truvestments Capital LLC50$14Held
Cornerstone Planning Group LLC5$1Held
MORGAN STANLEY3$1−$2Cut−$2

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.